The PE Ratio as of December 2024 (TTM) for Algernon Pharmaceuticals Inc. (AGNPF) is -2.20

According to Algernon Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -2.20. This represents a change of -97.55% compared to the average of -89.83 of the last 4 quarters.

Algernon Pharmaceuticals Inc. (AGNPF) Historical PE Ratio (quarterly & annually)

How has AGNPF PE Ratio performed in the past?

The mean historical PE Ratio of Algernon Pharmaceuticals Inc. over the last ten years is -3.56. The current -2.20 PE Ratio has changed 6.08% with respect to the historical average. Over the past ten years (40 quarters), AGNPF's PE Ratio was at its highest in in the May 2024 quarter at 0.60. The PE Ratio was at its lowest in in the February 2024 quarter at -358.92.

Algernon Pharmaceuticals Inc. (AGNPF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Algernon Pharmaceuticals Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Algernon Pharmaceuticals Inc. (AGNPF) Average PE Ratio

How has AGNPF PE Ratio performed in the past?

The current PE Ratio of Algernon Pharmaceuticals Inc. (AGNPF) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Algernon Pharmaceuticals Inc. (AGNPF) PE Ratio vs. Peers

How is AGNPF’s PE Ratio compared to its peers?

Algernon Pharmaceuticals Inc.’s PE Ratio is less than Cellectis S.A. (-1.62), greater than Biotron Limited (-4.46), less than Resverlogix Corp. (-1.23), greater than Small Pharma Inc. (-2.26), greater than Covalon Technologies Ltd. (-98.57), less than Adynxx, Inc. (0), less than Ascletis Pharma Inc. (0), greater than BioCardia, Inc. (-11.53), less than Wesana Health Holdings Inc. (-0.73), less than BioVaxys Technology Corp. (-0.30), greater than GH Research PLC (-2.93), greater than AXIM Biotechnologies, Inc. (-8.90), less than Bioasis Technologies Inc. (-0.14), less than Mosaic ImmunoEngineering Inc. (0), greater than Ceapro Inc. (-16.17), greater than null (-2.83),

Build a custom stock screener for Algernon Pharmaceuticals Inc. (AGNPF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Algernon Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Algernon Pharmaceuticals Inc. (AGNPF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Algernon Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.